BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22579524)

  • 1. Effect of HIV protease inhibitors on New World Leishmania.
    Demarchi IG; Silveira TG; Ferreira IC; Lonardoni MV
    Parasitol Int; 2012 Dec; 61(4):538-44. PubMed ID: 22579524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily.
    Konopnicki D; De Wit S; Poll B; Crommentuyn K; Huitema A; Clumeck N
    HIV Med; 2005 Jan; 6(1):1-6. PubMed ID: 15670245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV drugs, lopinavir/ritonavir and atazanavir, modulate innate immune response triggered by Leishmania in macrophages: the role of NF-κB and PPAR-γ.
    Alves ÉAR; de Miranda MG; Borges TK; Magalhães KG; Muniz-Junqueira MI
    Int Immunopharmacol; 2015 Feb; 24(2):314-324. PubMed ID: 25545854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of the variability of indinavir drug levels when boosted with ritonavir in HIV-infected children.
    Curras V; Hocht C; Mangano A; Niselman V; Mariño Hernández E; Cáceres Guido P; Mecikovsky D; Bellusci C; Bologna R; Sen L; Rubio MC; Bramuglia GF
    Pharmacology; 2009; 83(1):59-66. PubMed ID: 19052483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
    Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
    J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
    Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
    J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
    Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
    Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring.
    Wasmuth JC; Rodermann E; Voigt E; Vogel M; Lauenroth-Mai E; Jessen A; Burger D; Rockstroh JK
    Eur J Med Res; 2007 Jul; 12(7):289-94. PubMed ID: 17933700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity.
    Wasmuth JC; Lambertz I; Voigt E; Vogel M; Hoffmann C; Burger D; Rockstroh JK
    Eur J Clin Pharmacol; 2007 Oct; 63(10):901-8. PubMed ID: 17690876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indinavir-ritonavir combination: pharmacologic results and tolerance in patients infected by HIV].
    Bani-Sadr F; Perré P; Peytavin G; Bernard L; Melchior JC; Perronne C; de Truchis P
    Presse Med; 2001 Apr; 30(15):731-5. PubMed ID: 11360738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
    Dragsted UB; Gerstoft J; Pedersen C; Peters B; Duran A; Obel N; Castagna A; Cahn P; Clumeck N; Bruun JN; Benetucci J; Hill A; Cassetti I; Vernazza P; Youle M; Fox Z; Lundgren JD;
    J Infect Dis; 2003 Sep; 188(5):635-42. PubMed ID: 12934178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
    Soares DC; Andrade AL; Delorenzi JC; Silva JR; Freire-de-Lima L; Falcão CA; Pinto AC; Rossi-Bergmann B; Saraiva EM
    Parasitol Int; 2010 Jun; 59(2):173-7. PubMed ID: 20096374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.